Results 201 to 210 of about 131,634 (310)

Comparison of Safety of Different Vaccine Boosters Following Two-Dose Inactivated Vaccines: A Parallel Controlled Prospective Study. [PDF]

Vaccines (Basel), 2022
Lin ZQ, Wu JN, Huang RD, Xie FQ, Li JR, Zheng KC, Zhang DJ.   +6 more
europepmc   +1 more source

Recent advances of emergent extraction technologies to enhance bioactive compounds extraction of microalgae—An overview towards application in cosmetics

International Journal of Cosmetic Science, EarlyView.
Microalgae extracts show immense potential in cosmetics for their bioactivities; emerging extraction techniques enhance bioactive compound yield from microalgae. Abstract Microalgae have attracted significant interest in numerous sectors, particularly in the cosmetic industries, owing to their rich composition of bioactive compounds. This paper aims to
Alireza Mousakhani Ganjeh, Lucília da P. da Silva, Carlos A. Pinto, Rosário Martins, Alexandra P. Marques, Jorge A. Saraiva   +5 more
wiley   +1 more source

Predicting SARS-CoV-2-specific CD4⁺ and CD8⁺ T-cell responses elicited by inactivated vaccines in healthy adults using machine learning models. [PDF]

Clin Exp Med
Ning J, Ren Y, Zhang Z, Zeng X, Wang Q, Xie J, Xu Y, Fan Y, Li H, Zhai A, Li B, Wu C, Chen Y.   +12 more
europepmc   +1 more source

Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SYS6006, as a fourth-dose booster following three doses of inactivated vaccines in healthy adults: an open-labeled Phase 1 trial. [PDF]

Life Metab, 2023
Gui Y, Cao Y, He J, Zhao C, Zheng W, Qian L, Cheng J, Yu C, Yu C, Lou K, Liu G, Jia J.   +11 more
europepmc   +1 more source

IL‐2 silencing enables Tfh cell expansion during vaccination but is redundant for antibody production

Immunology &Cell Biology, EarlyView.
Sustained IL‐2 production delays T follicular helper cell differentiation and germinal center formation but does not alter final antibody titers or antigen‐specific humoral immunity after vaccination. Created in BioRender. Burton, A. (2026) https://BioRender.com/paggz41 Abstract Vaccines stimulate protective humoral immunity by coordinating lymphocyte ...
Silvia Innocentin, Ross McKenzie, Jayalini Assalaarachchi, Helena A Carslaw, Anusha Gupta, Sanne Cole, Adrian Liston, Michelle A Linterman, Louise Webb, Alice R Burton   +9 more
wiley   +1 more source

Evaluation of antibody responses in healthy individuals receiving SARS-CoV-2 inactivated vaccines. [PDF]

Biosaf Health
Liu Z, Cai L, Xing M, Qiao N, Liu J, Li X, Zhang C, Tang N, Xu Z, Guo Y, Lu R, Zhou D.   +11 more
europepmc   +1 more source

Inactivated vaccines prevent severe COVID-19 in patients infected with the Delta variant: A comparative study of the Delta and Alpha variants from China. [PDF]

J Med Virol, 2022
Ye C, Lv Y, Kuang W, Yang L, Lu Y, Gu J, Ding F, Shen H, Yang Y.   +8 more
europepmc   +1 more source

Age‐related differences in mRNA vaccine immunogenicity and adjuvancy

Immunology &Cell Biology, EarlyView.
Older people often respond poorly to mRNA vaccines, with reduced T and B cell responses, but they also bear more morbidity and mortality for infectious diseases. This paper maps age‐related changes in mechanisms of adjuvancy that can shape the immunogenicity of mRNA vaccine in a mouse model. Created in BioRender.
Shivali Savita Chinni, Gemma S Trollope, Patrick Leung, Jonathan L McQualter, Chee Wah Tan, Linfa Wang, Leonard Lim, Adam K Wheatley, Jennifer A Juno, Stephen J Kent, Hareth A Al‐Wassiti, Colin W Pouton, Kylie M Quinn   +12 more
wiley   +1 more source

Development and evaluation of inactivated vaccines incorporating a novel Senecavirus A strain-based Immunogen and various adjuvants in mice. [PDF]

Front Vet Sci
Wang B, Gao F, Hu R, Huyan H, Wang G, Cao Z, Zhao Y, Lu H, Song D, Gao F, He W, Lan Y.   +11 more
europepmc   +1 more source

Vaccination with SARS-CoV-2 inactivated vaccines reduced the risk of anxiety and depression in a population majored by health care workers during the recent omicron variant outbreak. [PDF]

Front Psychol, 2022
Zhao H, Yu X, Ye W, Wang R, Sheng J, Shi Y.   +5 more
europepmc   +1 more source